• HELICOS BIOSCIENCES CORP Financial Overview

  • Income Statement: HLCS

      2007 2006 Change ( 2006 - 2007  )
    Net Sales/Revenues 582,000.00 159,000.00 423,000.00 72.68%
    Gross Profit -1.01 M -794,000.00 -212,000.00 21.07%
    Net Income Before Extra Items/Preferred Div -36.80 M -20.58 M -16.22 M 44.08%
    Operating Income -38.49 M -21.14 M -17.35 M 45.07%
  • Cash Flow: HLCS

      2007 2006 Change ( 2006 - 2007  )
    Net Cash Flow - Financing 76.28 M 22.55 M 53.73 M 70.44%
    Net Cash Flow - Investing 1.39 M 4.00 M -2.61 M -188.04%
    Net Cash Flow/Operating Activities -32.80 M -16.53 M -16.27 M 49.60%
  • Balance Sheet: HLCS

      2007 2006 Change ( 2006 - 2007  )
    Total Assets 59.21 M 77.90 M -18.69 M -31.57%
    Total Liabilities 15.77 M 5.67 M 10.10 M 64.02%
    Shareholders Equity 43.44 M 72.23 M -28.79 M -66.27%
  • Key Ratios / Statistics: HLCS

    • Valuation

      Price/Earnings (TTM) -2.47
      Price/Sales (TTM) 233.04
      Price/Book (MRQ) 3.83
      Price/Cash Flow (TTM) 2.37
    • Profitability

      Gross Margin -172.85
      Operating Margin -6,613.06
      Profit Margin -6,323.88
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 11.30
      Current Ratio (MRQ) 6.71
      Long Term Debt-to-Equity (MRQ) 29.31
    • Management Effectiveness

      Return on Equity (TTM) -151.34
      Return on Assets (TTM) -104.13
      Return on Investments (TTM) -56.39